ThermoSmart® Versus Conventional Humidification in Continuous Positive Airway Pressure (CPAP)
NCT ID: NCT00751335
Last Updated: 2020-09-24
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
79 participants
INTERVENTIONAL
2006-08-31
2008-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Titration Pressures in Sleep Apnea Patients Using ThermoSmart® Versus Conventional Humidification
NCT00681083
Effects of Humidity (During CPAP Treatment) on Mucociliary Clearance in Patients With Obstructive Sleep Apnea
NCT00790166
Effect of Heated Humidity With Thermosmart™ Compared to an Intranasal Steroid in Improving Compliance and Nasal Symptoms in Patients Using Continuous Positive Airway Pressure
NCT00665977
A Comparison of CPAP With and Without Humidification: A Pilot Study
NCT02423681
Investigation of a Novel Positive Pressure Therapy to Rescue Patients Failing to Tolerate CPAP During an Initial Encounter
NCT00635206
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CPAP with ThermoSmart, then CPAP without ThermoSmart
CPAP with ThermoSmart is the application of CPAP with heated humidification and a heated breathing tube.
CPAP without ThermSmart is the application of CPAP with heated humidification without a heated breathing tube.
CPAP with ThermoSmart, then CPAP without ThermoSmart
CPAP with ThermoSmart is the application of CPAP with heated humidification and a heated breathing tube.
CPAP without ThermSmart is the application of CPAP with heated humidification without a heated breathing tube.
CPAP without ThermoSmart, then CPAP with ThermoSmart
CPAP with ThermoSmart is the application of CPAP with heated humidification and a heated breathing tube.
CPAP without ThermSmart is the application of CPAP with heated humidification without a heated breathing tube.
CPAP without ThermoSmart, then CPAP with ThermoSmart
CPAP with ThermoSmart is the application of CPAP with heated humidification and a heated breathing tube.
CPAP without ThermSmart is the application of CPAP with heated humidification without a heated breathing tube.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CPAP with ThermoSmart, then CPAP without ThermoSmart
CPAP with ThermoSmart is the application of CPAP with heated humidification and a heated breathing tube.
CPAP without ThermSmart is the application of CPAP with heated humidification without a heated breathing tube.
CPAP without ThermoSmart, then CPAP with ThermoSmart
CPAP with ThermoSmart is the application of CPAP with heated humidification and a heated breathing tube.
CPAP without ThermSmart is the application of CPAP with heated humidification without a heated breathing tube.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Previous diagnosis of OSA permitted, but patient must be novel to CPAP and no previous surgical intervention for OSA or treatment with an oral appliance.
3. AHI ≥ 15 OR AHI ≥ 5 + ESS ≥ 10 OR ESS ≥ 10 + a medical co-morbidity
4. Patient willing to give informed consent and follow study protocol.
Exclusion Criteria
2. Patient requires BiLevel PAP or supplemental oxygen
3. The patient is medically unstable (e.g. respiratory or cardiac failure)
4. Patient unwilling to give informed consent or follow study protocol.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Suburban Lung Associates
OTHER
Fisher and Paykel Healthcare
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clifford A Massie, PhD
Role: PRINCIPAL_INVESTIGATOR
Suburban Lung Asssociates
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Suburban Lung Associates
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Fisher \& Paykel Healthcare
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FPHC SLA 2008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.